Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ News / India/  WHO's Covaxin supply suspension needs to be addressed immediately to avoid EUL cancellation: MEA to Bharat Biotech
BackBack

WHO's Covaxin supply suspension needs to be addressed immediately to avoid EUL cancellation: MEA to Bharat Biotech

The MEA in a written communication to Dr V K Paul notified that several issues regarding vaccines and international travel by Indians have arisen and they should be addressed at the earliest.

WHO has announced the suspension of the vaccine's supply through UN procurement agencies pointing out deficiencies in good manufacturing practicePremium
WHO has announced the suspension of the vaccine's supply through UN procurement agencies pointing out deficiencies in good manufacturing practice

After Bharat Biotech's Covaxin supply has been suspended by WHO through UN procurement agencies, the ministry of external affairs suggested that the firm should immediately address the issue to avoid cancellation of the world health body's emergency use approval for the vaccine. 

The MEA in a written communication to Dr V K Paul, the convenor of a key empowered group on Covid vaccination, notified that several issues regarding vaccines and international travel by Indians are pointed out and they should be addressed at the earliest.  

Foreign Secretary Harsh Vardhan Shringla said, "The issues pertain to m-RNA based booster dose requirement by countries which, in effect, negates our effort to obtain recognition of Covishield and Covaxin, suspension of supply of Covaxin by WHO, acceptance of Corbevax and Covaxin-based vaccination certificates for children and international travel by Indians vaccinated with Sputnik-V." 

Recently, WHO has announced the suspension of the vaccine's supply through UN procurement agencies pointing out deficiencies in good manufacturing practices. However, WHO maintained that the vaccine is effective and there is no safety concern, it has recommended that countries using the vaccine take action as appropriate.

Owing to this, Shringla said in the letter, "This situation further complicates the acceptance of Covaxin-based Indian vaccination certificates by other countries, especially by European Union member states such as Germany and France." 

It stated that a proper response or policy from the government needs to be formulated on the issue and on further pursuance of recognition of Covaxin and Covaxin-based certificates by other countries.

"Bharat Biotech must address the matter immediately through DCGI and WHO and avoid any situation that may lead to cancellation of WHO's EUL for Covaxin in future," Shringla said, requesting that a meeting of the empowered group-five be convened to address the issues.

In the communication, he also mentioned some authorities abroad, such as in Hong Kong, have begun demanding vaccination certificates for children and only accept m-RNA based jabs for them.

“It is necessary to quickly initiate the process of recognition of the Corbevax vaccine and its certificate by other countries while Biological E continues to pursue WHO's EUL for it," Shringla said.

(With inputs from agencies)

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 28 Apr 2022, 08:06 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App